Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Oxygen Therapy (long-term)
Treatment for Emphysema
Typical Dosage: 1-5 liters/minute via nasal cannula
Effectiveness
90%
Safety Score
95%
Clinical Trials
2
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
1-5 liters/minute via nasal cannula
Time to Effect
immediate for oxygenation, months-years for survival
Treatment Duration
lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$4,800
Side Effect Mgmt:$100
Total Annual:$4,900
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$25,000/QALY
QALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$5,158
Oxygen Therapy (long-term) Outcomes
for Emphysema
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+95%
Common Side Effects
Nasal irritation/dryness
+25%
Skin breakdown (from cannulas)
+5%
Fire hazard (rare)
+0.01%
CO2 retention (if flow too high)
+3%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
1 active trial recruiting for Oxygen Therapy (long-term) in Emphysema
The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease
NCT06652776ENROLLING BY INVITATION
10K participants
OBSERVATIONAL
Milan, Italy
Started: Sep 30, 2024
Completed Clinical Trials
1 completed trial for Oxygen Therapy (long-term) in Emphysema
The CaNadian Standardized Pulmonary Rehabilitation Efficacy Trial
NCT02917915COMPLETEDNA
207 participants
INTERVENTIONAL
Edmonton, Canada
Started: Jan 1, 2017